PMS-APREMILAST

Identification of Pms-Apremilast

No description

Google image searchProduct monograph

Active ingredient

apremilast, 30 MG

DIN: 02521733

Dosage form(s): TABLET

Route(s) of administration: ORAL

Schedule: Prescription

Company: PHARMASCIENCE INC

Date: 14-NOV-2022

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AA — Selective immunosuppressants (ATC, ATC/DDD)
• L04AA32 — APREMILAST (ATC/DDD)

External Links for Pms-Apremilast

Search on Google

• Pms-Apremilast side effects
• Pms-Apremilast dosage
• apremilast side effects
• apremilast dosage

Pharmascience Inc

Go to Pharmascience website to see drug product details. Sometimes you can find pms-apremilast photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.